Renaissance Technologies’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$127K Buy
+54,900
New +$127K ﹤0.01% 3262
2025
Q1
Sell
-878,448
Closed -$1.52M 3846
2024
Q4
$1.52M Buy
+878,448
New +$1.52M ﹤0.01% 2226
2024
Q3
Sell
-41,100
Closed -$92.1K 3899
2024
Q2
$92.1K Sell
41,100
-287,400
-87% -$644K ﹤0.01% 3198
2024
Q1
$943K Sell
328,500
-768,900
-70% -$2.21M ﹤0.01% 2525
2023
Q4
$1.94M Buy
1,097,400
+499,400
+84% +$884K ﹤0.01% 1962
2023
Q3
$1.89M Buy
598,000
+373,600
+166% +$1.18M ﹤0.01% 1903
2023
Q2
$148K Sell
224,400
-25,200
-10% -$16.6K ﹤0.01% 3363
2023
Q1
$199K Sell
249,600
-270,200
-52% -$215K ﹤0.01% 3288
2022
Q4
$1.18M Buy
519,800
+101,300
+24% +$229K ﹤0.01% 2435
2022
Q3
$808K Sell
418,500
-105,100
-20% -$203K ﹤0.01% 2627
2022
Q2
$1.95M Buy
523,600
+273,100
+109% +$1.02M ﹤0.01% 2212
2022
Q1
$1.63M Buy
+250,500
New +$1.63M ﹤0.01% 2381